• Profile
Close

Randomized investigator-blinded comparative study of moisturizer containing 4-t-butylcyclohexanol and licochalcone A vs 0.02% triamcinolone acetonide cream in facial dermatitis

Journal of Cosmetic Dermatology Feb 12, 2018

Boonchai W, et al. - For the treatment of facial dermatitis, the effectiveness of moisturizer containing 4-t-butylcyclohexanol, which acted as a sensitivity regulator, and licochalcone A, an anti-inflammatory agent from the licorice plant Glycyrrhiza inflata, was comparatively analyzed with that of 0.02% triamcinolone acetonide (TA). In improving facial dermatitis, the test facial moisturizer was seen to be slower than 0.02% TA. However, this test moisturizer illustrated greater benefit in erythema control and skin hydration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay